Table 1. Patients with concomitant treatment (%)
| Baseline | Mo.3 | Mo.6 | Mo.12 | Mo.24 | Mo.36 | Mo.48 | |
|---|---|---|---|---|---|---|---|
| NSAIDs | 81.4 | 68.1 | 62 | 53.0 | 46.6 | 47.3 | 43.8 |
| Corticosteroids | 44 | 37.4 | 33 | 29.1 | 25.7 | 23 | 24.2 |
| Methotrexate | 72.7 | 65.8 | 59.4 | 58.9 | 50.5 | 45.2 | 42.8 |
| Other DMARDs | 18.3 | 14.1 | 12.8 | 12.2 | 11.5 | 12.7 | 10.8 |
| Monotherapy* | 17.9 | 26.4 | 32.8 | 34.3 | 42.6 | 45.8 | 51.5 |
*No conventional DMARD.